CN Stock MarketDetailed Quotes

300016 Beijing Beilu Pharmaceutical

Watchlist
  • 4.91
  • -0.03-0.61%
Market Closed May 29 15:00 CST
2.42BMarket Cap-33175P/E (TTM)

Beijing Beilu Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beijing Beilu Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

207.51M

+10.35%
EPS(YoY)

0.04

-0.95%
Analyst Rating

Buy

May 29, 2024

Beijing Beilu Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2020/FY827.338M / 1.029B--
--2019/FY819.119M / 794.000M--
DatePeriodRevenue/EstimateEarnings Call
--2020/FY827.338M / 1.029B--
--2019/FY819.119M / 794.000M--

Beijing Beilu Pharmaceutical Earnings Reports

  • Hokuriku Pharmaceutical: Annual Report 2023

    Apr 21 12:00 ET

  • Hokuriku Pharmaceutical: 2023 Annual Report Summary

    Apr 21 12:00 ET

  • Hokuriku Pharmaceutical: First quarter report 2024

    Apr 21 12:00 ET

  • Hokuriku Pharmaceutical: 2023 Annual Results Forecast

    Jan 30 04:50 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 29, 2024

    Buy

    • Strong Buy

      0.00%

    • Buy

      100.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg